Physician profile
Ingrid Rund
NPI 1902812514
$1,742.08
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $37.51 · 2021: $176 · 2022: $322 · 2023: $702 · 2024: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $490.91 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $266.63 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $189.97 | 2021-2024 | Verquvo |
| Pfizer INC. | $158.40 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.78 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $99.46 | 2021-2024 | Camzyos, Eliquis |
| Amgen INC. | $98.91 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $86.18 | 2019-2023 | Watchman Access System |
| Lexicon Pharmaceuticals, INC. | $54.67 | 2023-2024 | Inpefa |
| Abbott Laboratories | $50.77 | 2023-2024 | Mitraclip |
| Scpharmaceuticals INC. | $31.48 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $21.66 | 2023 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $20.93 | 2023 | Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $19.08 | 2023 | Arcalyst |
| Novo Nordisk INC | $18.94 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $16.19 | 2022 | |
| Gilead Sciences, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Rund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.